Trademark: 98354441
Status Date
Thursday, August 15, 2024
Filing Date
Friday, January 12, 2024
5 pharmaceutical preparations for human use; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions
44 Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
42 providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
The mark consists of two same size arches with rounded end points. The front arch begins to the left of the back arch and covers a portion of the back arch. The front arch appears in a gradient from left to right from purple to magenta. The back arch appears in a gradient from left to right from pink to orange.
The color(s) purple, magenta, pink, and orange is/are claimed as a feature of the mark.
Jan 12, 2024
New Application Entered
May 5, 2024
Notice Of Design Search Code E-Mailed
May 5, 2024
New Application Office Supplied Data Entered
May 22, 2024
Assigned To Examiner
May 30, 2024
Notification Of Priority Action E-Mailed
May 30, 2024
Priority Action Written
May 30, 2024
Priority Action E-Mailed
Jul 31, 2024
Application Extension Granted/Receipt Provided
Jul 31, 2024
Application Extension To Response Period - Received
Aug 15, 2024
Notification Of Priority Action E-Mailed
Aug 15, 2024
Priority Action E-Mailed
Aug 15, 2024
Priority Action Written
Aug 27, 2024
Application Extension To Response Period - Received
Aug 27, 2024
Application Extension Granted/Receipt Provided
Trademark Alertz updated from USPTO on 2030-01-24
